For drug development and discovery, pharmacies and biotech firms typically use label-free Array Systems. They are used in array formats to monitor molecular interactions. The drug discovery process has become less effective as a result of the limitations and drawbacks associated with traditional labelled technologies. It has resulted in the creation of label-free array systems. Label-free array systems eliminate the need for dyes, reagents, engineered cells, and tags while providing highly sensitive measurements for endogenous targets in live cell assays. Interference-based techniques are used in these systems. Surface Plasmon Resonance (SPR), Scanning Kelvin Nanoprobes, Atomic Force Microscopy, and other techniques are used in label-free detection. SPR is the most widely used technique in label-free array systems.

Increase in the volume of biotechnology companies and pharmaceutical organisations all over the world is a critical factor escalating market growth, as is an increase in the reduction of resources required for drug discovery using this technique, as well as an increase in the levels of investments and expenditure incurred in R&D by various biotechnology organisations, among other factors driving the label-free array systems market. Furthermore, advancements in technology and modernization in the healthcare sector will create new opportunities for the label-free array systems market during the forecasted period.